Context Therapeutics Inc. - Common Stock — Flux de trésorerie (NASDAQ:CNTX) | MetaTrader

Afficher le graphique complet Full chart

Financials

Aperçu Relevé Statistiques

Trimestriel Annuel

Flux de trésorerie liés aux activités d'exploitation -8.8 M-13.55 M-21.05 M-14.56 M-26.39 M -32.79 M Flux de trésorerie liés aux activités d'investissement -250 K-536.84 K0-14.76 M-2.03 M -2.04 M Flux de trésorerie liés aux activités de financement 58.39 M-102.07 K0109.29 M-15.27 K 0 Flux de trésorerie disponible -8.8 M-13.55 M-21.05 M-14.56 M-26.42 M -32.82 M

Nouvelles

Pourquoi les actions de GH Research sont échangées à la hausse de 18% ; Voici 20 actions qui bougent avant l'ouverture du marché | Benzinga France

Why GH Research Shares Are Trading Higher By 18%; Here Are 20 Stocks Moving Premarket - BioAtla (NASDAQ:BCAB), ChowChow Cloud Internatio (AMEX:CHOW)

This Blacksky Technology Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Monday - AirJoule Technologies (NASDAQ:AIRJ), BlackSky Technology (NYSE:BKSY)

Step Pharma appoints Karen Smith as chief medical officer

This Synopsys Analyst Begins Coverage On A Bearish Note; Here Are Top 5 Initiations For Thursday - Context Therapeutics (NASDAQ:CNTX), Absci (NASDAQ:ABSI)

Rare Stock Picks In June 2025 - From 26 Discerning Analysts

Context Therapeutics: Undervalued Cancer Fighter (NASDAQ:CNTX)

Citizens JMP affirms $4 price target on Context Therapeutics stock

Context Therapeutics Announces CTIM-76 Trial in Progress Poster Presentation at 2025 ASCO Meeting

Citizens JMP highlights key ASCO presentations

Centrexion Therapeutics stock hits 52-week low at $0.55

Citizens JMP highlights bispecific antibodies progress